Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,891 papers from all fields of science
Search
Sign In
Create Free Account
lopinavir
Known as:
LPV
, Lopinavir [Chemical/Ingredient]
, N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide
A drug used with another drug, called ritonavir, to treat infection with HIV (the virus that causes AIDS). It is also being studied in the treatment…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
22 relations
Narrower (4)
ABT 378
ABT-378/r
Kaletra
lopinavir-ritonavir drug combination
Acquired Immunodeficiency Syndrome
Drug Allergy
HIV Protease Inhibitors [MoA]
In Blood
Expand
Broader (4)
Antiviral Agents
Cytochrome P-450 CYP3A Inhibitors
HIV Protease Inhibitors
Protease Inhibitors
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Therapeutic management of patients with COVID-19: a systematic review
M. Tobaiqy
,
M. Qashqary
,
+4 authors
N. Helmi
Infection Prevention in Practice
2020
Corpus ID: 215790310
Highly Cited
2012
Highly Cited
2012
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind…
J. Molina
,
A. LaMarca
,
+7 authors
S. Chuck
Lancet. Infectious Diseases (Print)
2012
Corpus ID: 21859703
Review
2006
Review
2006
MDR- and CYP3A4-mediated drug-herbal interactions.
D. Pal
,
A. Mitra
Life Science
2006
Corpus ID: 28646080
Review
2001
Review
2001
Principles and practice of HIV‐protease inhibitor pharmacoenhancement
Graeme Moyle
,
D. Back
HIV Medicine
2001
Corpus ID: 9239409
Continually maintaining maximally suppressive drug concentrations represents a key defence against the emergence of resistance…
Expand
Highly Cited
1999
Highly Cited
1999
Identification of Linear Parameter-Varying Systems Using Nonlinear Programming
Lawton H. Lee
,
K. Poolla
1999
Corpus ID: 18550828
This paper deals with the identification of a linear parameter-varying (LPV) syster whose parameter dependence can be written as…
Expand
Highly Cited
1998
Highly Cited
1998
Dutch Normal-Pressure Hydrocephalus Study: randomized comparison of low- and medium-pressure shunts.
A. Boon
,
J. Tans
,
+7 authors
J. Hermans
Journal of Neurosurgery
1998
Corpus ID: 19068788
OBJECT The goal of this prospective study was to compare outcome after placement of a low- or medium-pressure shunt in patients…
Expand
Review
1996
Review
1996
Antiretroviral therapy in adults.
Barbara Wise
Journal of the American Academy of Nurse…
1996
Corpus ID: 11486948
In 1993, HIV became the leading cause of death among persons 25 to 44 years old (Centers for Disease Control and Prevention [CDC…
Expand
Highly Cited
1993
Highly Cited
1993
Gain-Scheduled Missile Autopilot Design Using Linear Parameter Varying Transformations
J. Shamma
,
J. Cloutier
1993
Corpus ID: 9810191
This paper presents a gain-scheduled design for a missile longitudinal autopilot. The gain-scheduled design is novel in that it…
Expand
Highly Cited
1993
Highly Cited
1993
Control of Parametrically-Dependent Linear Systems: A Single Quadratic Lyapunov Approach
G. Becker
,
A. Packard
,
D. Philbrick
,
G. Balas
American Control Conference
1993
Corpus ID: 38368732
In this paper two parameter-dependent control problems for linear, parametrically varying (LPV) systems are presented. Sufficient…
Expand
Review
1992
Review
1992
Common and unique features of T antigens encoded by the polyomavirus group
J. Pipas
Journal of Virology
1992
Corpus ID: 25670266
Although 12 different members of the polyomavirus group have now been identified, only SV40 and PyV have been studied extensively…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE